“I think people should have the patience to read the internet and look at what our articles are,” Ella had said.
In a series of tweets, Dr Sudhakar stated that Bharat Biotech was a reputed company with credibility and experience.
“Covaxin’s phase-3 clinical trial involves 24,000 volunteers & it’s data will be available soon.
I humbly appeal to everyone, not as a Health Minister but as a fellow medical professional, to refrain from unwarranted criticism which discredits the hard work of our scientists,” Sudhakar tweeted on Tuesday.
The health minister said Bharat Biotech is